BDBM270930 4-(azepan-1-yl)-7-(benzenesulfonyl)-5H-pyrrolo[3,2-d]pyrimidin-6-amine::US10059713, Example 48
SMILES: Nc1[nH]c2c(ncnc2c1S(=O)(=O)c1ccccc1)N1CCCCCC1
InChI Key: InChIKey=IYFCPFLUMCGQRH-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free fatty acid receptor 2 (Homo sapiens (Human)) | BDBM270930 (4-(azepan-1-yl)-7-(benzenesulfonyl)-5H-pyrrolo[3,2...) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 209 | n/a | n/a | n/a | n/a |
TAKEDA PHARMACEUTICAL COMPANY LIMITED US Patent | Assay Description GPR43 agonist/PAM activity was determined by measuring changes in intracellular calcium levels using a Ca2+ sensitive fluorescent dye. The changes in... | US Patent US10059713 (2018) BindingDB Entry DOI: 10.7270/Q2251M7X | |||||||||||
More data for this Ligand-Target Pair |